BioTelemetry (BEAT) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq set to open higher as AI stocks rebound ahead of earnings rush
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month high with Hormuz transits in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- S&P 500, Nasdaq set to open higher as AI stocks rebound ahead of earnings rush
- Microsoft pulls out of UK Nscale data centre deal over power delay
- AST SpaceMobile partners with four European operators on MSS spectrum
- Eos Energy Q3 2026 preliminary revenue up 169% year over year
BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results
February 26, 2020 4:05 PM ESTAnnounces Record Quarterly and Full Year Results
MALVERN, Pa., Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter and year ended December 31, 2019.
Quarter Highlights
Recognized quarterly revenue of $112.0 millionReached 8.1% year-over-year quarterly revenue growthAchieved 30th consecutive quarter of year-over-year revenue growthReported GAAP net income of $1.6 million, or 1.4% of revenueRealized... More


